Inhibitory Effect of Sargassum fusiforme and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo

Viruses. 2021 Mar 25;13(4):548. doi: 10.3390/v13040548.

Abstract

Sargassum fusiforme, a plant used as a medicine and food, is regarded as a marine vegetable and health supplement to improve life expectancy. Here, we demonstrate that S. fusiforme extract (SFE) has antiviral effects against respiratory syncytial virus (RSV) in vitro and in vivo mouse model. Treatment of HEp2 cells with a non-cytotoxic concentration of SFE significantly reduced RSV replication, RSV-induced cell death, RSV gene transcription, RSV protein synthesis, and syncytium formation. Moreover, oral inoculation of SFE significantly improved RSV clearance from the lungs of BALB/c mice. Interestingly, the phenolic compounds eicosane, docosane, and tetracosane were identified as active components of SFE. Treatment with a non-cytotoxic concentration of these three components elicited similar antiviral effects against RSV infection as SFE in vitro. Together, these results suggest that SFE and its potential components are a promising natural antiviral agent candidate against RSV infection.

Keywords: RSV; Sargassum fusiforme; docosane; eicosane; tetracosane; therapeutic effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / analysis
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Biological Products / analysis*
  • Biological Products / pharmacology*
  • Cell Line
  • Disease Models, Animal
  • Humans
  • Lung / drug effects
  • Lung / virology
  • Mice
  • Mice, Inbred BALB C
  • Phenols / pharmacology
  • Respiratory Syncytial Virus Infections / drug therapy
  • Respiratory Syncytial Virus, Human / drug effects*
  • Sargassum / chemistry*
  • Viral Load / drug effects
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Biological Products
  • Phenols